Cargando…
Reply to letter to the editor “antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Respiratory Society. Published by Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988710/ https://www.ncbi.nlm.nih.gov/pubmed/36947984 http://dx.doi.org/10.1016/j.resinv.2023.02.004 |
| _version_ | 1784901625428574208 |
|---|---|
| author | Narita, Daisuke Ebina-Shibuya, Risa |
| author_facet | Narita, Daisuke Ebina-Shibuya, Risa |
| author_sort | Narita, Daisuke |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9988710 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The Japanese Respiratory Society. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99887102023-03-07 Reply to letter to the editor “antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment” Narita, Daisuke Ebina-Shibuya, Risa Respir Investig Letter to the Editor The Japanese Respiratory Society. Published by Elsevier B.V. 2023-05 2023-03-07 /pmc/articles/PMC9988710/ /pubmed/36947984 http://dx.doi.org/10.1016/j.resinv.2023.02.004 Text en © 2023 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Narita, Daisuke Ebina-Shibuya, Risa Reply to letter to the editor “antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment” |
| title | Reply to letter to the editor “antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment” |
| title_full | Reply to letter to the editor “antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment” |
| title_fullStr | Reply to letter to the editor “antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment” |
| title_full_unstemmed | Reply to letter to the editor “antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment” |
| title_short | Reply to letter to the editor “antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment” |
| title_sort | reply to letter to the editor “antibody responses to second doses of covid-19 vaccination in lung cancer patients: comment” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988710/ https://www.ncbi.nlm.nih.gov/pubmed/36947984 http://dx.doi.org/10.1016/j.resinv.2023.02.004 |
| work_keys_str_mv | AT naritadaisuke replytolettertotheeditorantibodyresponsestoseconddosesofcovid19vaccinationinlungcancerpatientscomment AT ebinashibuyarisa replytolettertotheeditorantibodyresponsestoseconddosesofcovid19vaccinationinlungcancerpatientscomment |